Independent Advisory Practice · Seoul, Korea
Specialized guidance for overseas medical device companies navigating Korea's health insurance reimbursement system — from market entry through post-listing management.
Who We Are
JB & Associates is an independent advisory practice specializing in Korea market access, reimbursement strategy, health insurance listing, reimbursement management, and new health technology assessment pathways for medical devices.
We support overseas and international medtech companies of all sizes — from emerging innovators to established manufacturers — seeking to enter or expand in Korea.
The practice is led by JongBae "JB" Kim, whose reimbursement and market access experience dates back to the formative years of Korea's medical device reimbursement framework. We are particularly suited for companies that need ongoing access to experienced Korea reimbursement expertise, but do not yet have a dedicated local market access team.
Specialized Areas
Rather than broad general consulting, JB & Associates focuses on selected areas where deep Korean reimbursement experience is critical.
Strategic advisory for entering Korea’s healthcare reimbursement system, including pathway assessment, stakeholder mapping, and execution planning.
Support for reimbursement listing strategy, product classification, evidence positioning, and preparation for payer review.
Advisory on Korea’s nHTA pathway, including existing technology review, evaluation deferral, and linkage to reimbursement decisions.
Support for medical procedure reimbursement, including procedure code strategy, fee pathway review, and clinical-use positioning.
Strategy for expanding reimbursement coverage criteria based on clinical evidence, unmet needs, and real-world utilization.
Ongoing support for listed products, including re-evaluation response, reimbursement maintenance, and risk management.
Our Approach
Korea's reimbursement environment is complex, highly regulated, and continuously evolving. Successful market access requires more than regulatory approval — it requires a practical understanding of reimbursement pathways, listing requirements, evidence expectations, stakeholder dynamics, and actual decision-making processes.
JB & Associates provides practical, evidence-based, and commercially realistic advice for companies navigating Korea's health insurance and reimbursement environment.
Our role is to help clients make informed decisions before, during, and after market entry in Korea.
If your company is evaluating Korea reimbursement listing, coverage strategy, or new health technology assessment pathways, JB & Associates can support you as a local market access and reimbursement advisor.